Gated Volumetric-Modulated Arc Therapy vs. Tumor-Tracking CyberKnife Radiotherapy as Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Dosimetric Comparison Study Focused on the Impact of Respiratory Motion Managements
Yoon K, Kwak J, Cho B, Park JH, Yoon SM, Lee SW, Kim JH | PLoS One | 2016
Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver Metastases
Stintzing S, Einem JV, Fueweger C, Haidenberger A, Fedorov M, Muavcevic A | Cancer Res Treat | 2019
Single community-based institutional series of stereotactic body radiation therapy (SBRT) for treatment of liver metastases
Anstadt EJ, Shumway R, Colasanto J, Grew D | J Gastrointest Oncol | 2019
Challenges of BCLC stage C hepatocellular carcinoma: Results of a single-institutional experience on stereotactic body radiation therapy
Que J, Lin CH, Lin LC, Ho CH | Medicine (Baltimore) | 2020
Cyberknife Radiosurgery in Hepatocellular Carcinoma
Memon B, Kadri S, Sultana N, Saeed K, Ahmed N, Mahmood T | J Coll Physicians Surg Pak | 2021
Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study
Dutta D, Tatineni T, Yarlagadda S, Gupte A, Reddy SK, Madhavan R, Nair H, Sasidharan A, Kannan R, Pottayil SG, Holla R, Sudhindran S | Indian J Gastroenterol | 2021
Hepatic Resection Versus Stereotactic Body Radiation Therapy Plus Transhepatic Arterial Chemoembolization for Large Hepatocellular Carcinoma: A Propensity Score Analysis
Sun J, Li WG, Wang Q, He WP, Wang HB, Han P, Zhang T, Zhang AM, Fan YZ, Sun YZ, Duan XZ | J Clin Transl Hepatol | 2021
Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trial
Shi C, Li Y, Geng L, Shen W, Sui C, Dai B, Lu J, Pan M, Yang J. | Eur J Cancer | 2022
Stereotactic body radiotherapy (SBRT) for high-risk central pulmonary metastases
Lischalk JW, Malik RM, Collins SP, Collins BT, Matus IA, Anderson ED | Radiat Oncol. | 2016
Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation
Repka MC, Aghdam N, Kataria SK, Campbell L, Suy S, Collins SP, Anderson E, Lischalk JW, Collins BT | Radiat Oncol. | 2017
Factors affecting local control of pulmonary oligometastases treated with stereotactic body radiotherapy
Sharma A, Duijm M, Oomen-de Hoop E, Aerts JG, Verhoef C, Hoogeman M, Nuyttens JJ. | Acta Oncol | 2018
Long term efficacy and toxicity after stereotactic ablative reirradiation in locally relapsed stage III non-small cell lung cancer
Sumodhee S, Bondiau PY, Poudenx M, Cohen C, Naghavi AO, Padovani B, Maneval D, Gal J, Leysalle A, Ghalloussi H, Otto J, Doyen J | BMC Cancer | 2019
A 54 Gy in three fractions of stereotactic body radiotherapy using CyberKnife for T1b-2aN0M0 pathologically confirmed non-small cell lung cancer
Abe T, Ryuno Y, Iino M, Saito S, Aoshika T, Ohta T, Igari M, Hirai R, Kumazaki Y, Kaira K, Kagamu H, Ishida H, Noda SE, Kato S | Jpn J Clin Oncol. | 2021
Fiducial markers for stereotactic lung radiation therapy: review of the transthoracic, endovascular and endobronchial approaches
Alessio Casutt, Rémy Kinj, Esat-Mahmut Ozsahin, Christophe von Garnier, Alban Lovis | Eur Respir Rev | 2022
Image-Guided Robotic Radiosurgery for the Treatment of Lung Metastases of Renal Cell Carcinoma-A Retrospective, Single Center Analysis
Severin Rodler, Melanie Götz, Jan-Niclas Mumm, Alexander Buchner, Annabel Graser, Jozefina Casuscelli, Christian Stief, Christoph Fürweger, Alexander Muacevic, Michael Staehler | Cancers (Basel) | 2022
Safety and Efficacy of Stereotactic Ablative Radiotherapy for Ultra-Central Lung Cancer
Wang B, Dong Y, Yu X, Li F, Wang J, Chen H, Niu Z, Song Y, Yuan Z, Tao Z | Front Oncol | 2022
High-dose stereotactic body radiotherapy using CyberKnife® for stage I peripheral lung cancer: a single-center retrospective study
Ryuno Y, Abe T, Iino M, Saito S, Aoshika T, Oota T, Igari M, Hirai R, Kumazaki Y, Kaira K, Kagamu H, Ishida H, Noda SE, Kato S | Radiat Oncol | 2022
Ultrasound-Guided Placement of Gold Fiducial Markers for Stereotactic Partial-Breast Irradiation
Seiler S, Rahimi A, Choudhery S, Garwood D, Spangler A, Cherian S, Goudreau S. | AJR Am J Roentgenol | 2016
Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast Irradiation
Rahimi A, Thomas K, Spangler A, Rao R, Leitch M, Wooldridge R, Rivers A, Seiler S, Albuquerque K, Stevenson S, Goudreau S, Garwood D, Haley B, Euhus D, Heinzerling J, Ding C, Gao A, Ahn C, Timmerman R. | Int J Radiat Oncol Biol Phys | 2017
First Experience in Korea of Stereotactic Partial Breast Irradiation for Low-Risk Early-Stage Breast Cancer
Lee WH, Chang JS, Kim MJ, Park VY, Yoon JH, Kim SY, Kim JY, Park HS, Kim SI, Cho YU, Park BW, Kim YB. | Front Oncol | 2020
